Global Hemostatic Pad Market Size By Type (Gelatin Hemostatic Pad, Fibrin Hemostatic Pad), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

lobal Hemostatic Pad Market Report Description

The Global Hemostatic Pad Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 4.5 billion by 2031, growing at a CAGR of 9.6% during the forecast period of 2023-2031.

Hemostatic pads are vital medical devices designed to control bleeding and facilitate clot formation in surgical, trauma, and emergency settings. The increasing prevalence of chronic diseases, a rise in surgical procedures, and growing demand for minimally invasive treatments are driving market expansion. Moreover, the growing adoption of advanced wound care products and the rising awareness about infection control are further boosting the demand for hemostatic pads globally.

Drivers

Rising Surgical Volumes

The increasing number of cardiovascular, orthopedic, and trauma-related surgeries worldwide is significantly boosting the demand for hemostatic pads to control intraoperative and postoperative bleeding.

Advancements in Wound Care Technologies

Continuous R&D efforts have led to the development of next-generation bioactive hemostatic pads that improve hemostasis efficiency while minimizing infection risks.

Growing Geriatric Population

An aging population prone to chronic illnesses and surgical interventions is driving the adoption of hemostatic pads in hospitals and home healthcare settings.

Restraints

High Cost of Advanced Hemostatic Pads

Premium hemostatic products with bioactive materials are costly, making them less affordable in cost-sensitive regions.

Limited Awareness in Developing Regions

Lack of awareness among healthcare professionals in emerging economies about the benefits of hemostatic pads restricts market penetration.

Opportunities

Increased Use in Minimally Invasive Surgeries

The growing popularity of laparoscopic and robotic surgeries presents an opportunity for compact and easy-to-use hemostatic pads.

Rising Demand in Ambulatory Surgical Centers (ASCs)

With the surge in outpatient procedures, the use of portable hemostatic solutions is expected to grow significantly.

Expansion into Emerging Markets

Increasing healthcare investments in Asia-Pacific and Latin America offer lucrative growth opportunities for manufacturers.

Market by System Type Insights

Oxidized Regenerated Cellulose Pads held the largest share in 2023, owing to their wide acceptance in surgical wound management.

Collagen-based Hemostatic Pads are expected to record the fastest growth rate due to their superior biocompatibility and enhanced clotting ability.

Market by End-Use Insights

Hospitals & Surgical Centers accounted for over 60% of the market share in 2023, driven by the increasing number of complex surgeries.

Ambulatory Surgical Centers (ASCs) are expected to exhibit the highest CAGR during the forecast period, driven by the rising trend of day-care surgeries.

Market by Regional Insights

North America dominated the market in 2023, supported by a robust healthcare infrastructure, high surgical volumes, and the presence of leading market players.

Asia-Pacific is projected to experience the fastest growth, fueled by growing healthcare spending, medical tourism, and an expanding patient population.

Europe holds a significant share due to the rising geriatric population and favorable reimbursement policies.

Competitive Scenario

Key players in the Global Hemostatic Pad Market include:

Johnson & Johnson (Ethicon)

Baxter International Inc.

3M Company

Medtronic plc

B. Braun Melsungen AG

Zimmer Biomet Holdings

Integra LifeSciences Corporation

CSL Behring

These companies focus on product innovation, strategic collaborations, and regional expansion to strengthen their market presence.

Key Developments:

In 2023, Baxter launched a next-generation bioactive hemostatic pad designed for faster clotting during cardiac surgeries.

Johnson & Johnson expanded its production capacity for advanced surgical hemostats in 2024 to meet growing demand in Asia.

In 2025, 3M announced a strategic partnership with a biotechnology firm to develop antimicrobial hemostatic pads with dual functionality for infection prevention.

Scope of Work – Global Hemostatic Pad Market

FAQs

What is the current market size of the Global Hemostatic Pad Market?

The market was valued at USD 2.1 billion in 2023.

What is the major growth driver of the Global Hemostatic Pad Market?

The primary driver is the rising number of surgical procedures and advancements in hemostatic technologies.

Which region is expected to dominate the Global Hemostatic Pad Market during the forecast period?

North America is expected to maintain dominance due to its high surgical volumes and advanced healthcare infrastructure.

Which segment accounted for the largest market share in the Global Hemostatic Pad Market?

Hospitals & Surgical Centers were the leading end-use segment in 2023.

Who are the key market players in the Global Hemostatic Pad Market?

Key players include Johnson & Johnson, Baxter, 3M, Medtronic, and B. Braun Melsungen AG.

Would you like me to also create a visually appealing infographic or chart summarizing the market data for better presentation?